BACM
MNTA

Blue Arrow Capital Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Blue Arrow Capital Management’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-90,000
Closed -$1.37M – 195
2015
Q1 		$1.37M Buy
90,000
+20,000
+29% +$260K 0.13% 115
2014
Q4 		$843K Buy
70,000
+50,000
+250% +$571K 0.1% 149
2014
Q3 		$227K Buy
+20,000
New +$228K 0.02% 177

Other funds holding MNTA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $2.41B AUM 286.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Blue Arrow Capital Management's MNTA Position: Q2 2015 in Review

Blue Arrow Capital Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q2 2015, closing a stake of 90,000 shares — an estimated $1.37M sold.

Blue Arrow Capital Management first reported a position in MNTA in Q3 2014 and held it in 3 quarters. The position peaked at $1.37M in Q1 2015. 162 funds tracked by Wall St. Rank hold MNTA as of Q2 2015.

  • Blue Arrow Capital Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q2 2015 after selling out during the quarter.
  • Blue Arrow Capital Management sold 90,000 Momenta Pharmaceuticals, Inc. shares in Q2 2015, an estimated $1.37M.
  • Blue Arrow Capital Management first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2014 and held it in 3 quarters.
  • Blue Arrow Capital Management's Momenta Pharmaceuticals, Inc. position peaked at $1.37M in Q1 2015.
  • 162 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q2 2015.

Based on Blue Arrow Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.